Skip to main content
Veterinary Medicines

DUOMYXIN, 3 400 IU/ml / 10 000 IU/ml, Eye drops, powder and solvent for solution for dogs and cats

Authorised
  • NEOMYCIN SULFATE
  • POLYMYXIN B SULFATE

Product identification

Medicine name:
DUOMYXIN, 3 400 IU/ml / 10 000 IU/ml, Eye drops, powder and solvent for solution for dogs and cats
DUOMYXIN 3400 IU/ml + 10 000 IU/ml Pulver und Lösungsmittel zur Herstellung von Augentropfen für Hunde und Katzen
Active substance:
  • NEOMYCIN SULFATE
  • POLYMYXIN B SULFATE
Target species:
  • Cat
  • Dog
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    17000.00
    international unit(s)
    /
    1.00
    Vial
  • POLYMYXIN B SULFATE
    50000.00
    international unit(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Eye drops, powder for solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01AA30
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Box of 1 vial of lyophilisate, 1 bottle of 5 ml solvent and 1 dropper

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tubilux Pharma S.p.A.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • V7008094.00.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0381/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden

Documents

Package Leaflet and Labelling

English (PDF)
Published on: 18/09/2025
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 17/10/2025

Final PuAR Duomyxin NL.V.0381.001.DC v.18092025.pdf

English (PDF)
Published on: 18/09/2025
Download